Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for
Endometrial Carcinoma and Atypica Page 1 Multicenter Phase II Study of Fertility-Sparing …

Thirty-nine patients with endometrioid adenocarcinoma (EA) and atypical hyperplasia (AH)
of the endometrium who received conservative treatment to preserve fertility were collected …

OBJECTIVE: We conducted the present study to clarify the clinicopathological characteristics
of mucinous adenocarcinoma. METHODS: Two hundred twenty-five patients were …

Objective To compare the recurrence-free interval (RFI) and safety profile in patients with
completely resected high-risk early-stage ovarian cancer treated with intravenous (IV) …

OBJECTIVE: The clinical management of atypical polypoid adenomyoma (APAM) of the
uterus remains to be established. We collected APAM cases, reviewed the …

Abstract Irinotecan (CPT-11) and cisplatin are singly active against cervical cancer. We
evaluated the efficacy and toxicity of CPT-11 plus cisplatin as first-line chemotherapy in …

Objective: To evaluate the sensitivity and specificity of endometrial cytology obtained by
intrauterine sample using a descriptive reporting format for endometrial cytological …

Background The therapeutic value of systematic lymphadenectomy for early-stage epithelial
ovarian cancer (EOC) is controversial. This study evaluates the survival impact and adverse …

Endometrial carcinoma is one of the most common gynecologic malignancies in Japan and
its incidence has increased recently. Although surgery is the cornerstone of the …

The efficacy and adverse events of neoadjuvant chemotherapy with irinotecan hydrochloride
and nedaplatin were evaluated in patients with bulky stage Ib2 to IIb cervical squamous cell …